Track the 한국유니온제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 한국유니온제약 has recorded 2 reports. The latest transaction was disclosed on 4 June 2026 (Purchase). Among the most active insiders: 부광약품. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
한국유니온제약 is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the Korea Exchange, XKRX.